Brief: CSAM Q3 Recurring Revenue Up 5% From Year Ago
Nov 30 (Reuters) - Csam Health Group AS CSAM.OL :
* CSAM DELIVERS GROWTH IN ARR AND 5% EBITDA MARGIN IN Q3-22
Source text for Eikon: ID:nObib5XCza
Further company coverage: CSAM.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))